University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner has participated in 1 clinical trials.
Therapeutic areas: Metastatic or Locally Advanced Unresectable Solid Tumors.
Sponsors: EMD Serono Research & Development Institute, Inc..
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner has 1 clinical trials on record. Their work covers Metastatic or Locally Advanced Unresectable Solid Tumors.
University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.